221 related articles for article (PubMed ID: 31418046)
1. Quality of life in patients with limited (1-3) brain metastases undergoing stereotactic or whole brain radiotherapy : A prospective study of the DEGRO QoL working group.
Steinmann D; Vordermark D; Gerstenberg W; Aschoff R; Gharbi N; Müller A; Schäfer C; Theodorou M; Wypior HJ; Geinitz H;
Strahlenther Onkol; 2020 Jan; 196(1):48-57. PubMed ID: 31418046
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
Steinmann D; Paelecke-Habermann Y; Geinitz H; Aschoff R; Bayerl A; Bölling T; Bosch E; Bruns F; Eichenseder-Seiss U; Gerstein J; Gharbi N; Hagg J; Hipp M; Kleff I; Müller A; Schäfer C; Schleicher U; Sehlen S; Theodorou M; Wypior HJ; Zehentmayr F; van Oorschot B; Vordermark D
BMC Cancer; 2012 Jul; 12():283. PubMed ID: 22780988
[TBL] [Abstract][Full Text] [Related]
4. Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial.
Kepka L; Tyc-Szczepaniak D; Osowiecka K; Sprawka A; Trąbska-Kluch B; Czeremszynska B
Clin Transl Oncol; 2018 Feb; 20(2):150-159. PubMed ID: 28616720
[TBL] [Abstract][Full Text] [Related]
5. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
[TBL] [Abstract][Full Text] [Related]
6. Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party.
Steinmann D; Schäfer C; van Oorschot B; Wypior HJ; Bruns F; Bölling T; Sehlen S; Hagg J; Bayerl A; Geinitz H; Hipp M; Vordermark D
Strahlenther Onkol; 2009 Mar; 185(3):190-7. PubMed ID: 19330297
[TBL] [Abstract][Full Text] [Related]
7. Fatigue scores in patients with brain metastases receiving whole brain radiotherapy.
Pulenzas N; Khan L; Tsao M; Zhang L; Lechner B; Thavarajah N; Barnes E; Danjoux C; Holden L; Lauzon N; Sheehan P; Bedard G; Chow E
Support Care Cancer; 2014 Jul; 22(7):1757-63. PubMed ID: 24510194
[TBL] [Abstract][Full Text] [Related]
8. Proxy assessment of patients before and after radiotherapy for brain metastases. Results of a prospective study using the DEGRO brain module.
Steinmann D; Vordermark D; Geinitz H; Aschoff R; Bayerl A; Gerstein J; Hipp M; van Oorschot B; Wypior HJ; Schäfer C
Strahlenther Onkol; 2013 Jan; 189(1):47-53. PubMed ID: 23161120
[TBL] [Abstract][Full Text] [Related]
9. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
[TBL] [Abstract][Full Text] [Related]
10. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.
Palmer JD; Klamer BG; Ballman KV; Brown PD; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
JAMA Oncol; 2022 Dec; 8(12):1809-1815. PubMed ID: 36264568
[TBL] [Abstract][Full Text] [Related]
11. Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases.
Wong E; Zhang L; Kerba M; Arnalot PF; Danielson B; Tsao M; Bedard G; Thavarajah N; Cheon P; Danjoux C; Pulenzas N; Chow E
Support Care Cancer; 2015 Sep; 23(9):2731-7. PubMed ID: 25663577
[TBL] [Abstract][Full Text] [Related]
12. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
13. Whole Brain Irradiation or Stereotactic RadioSurgery for five or more brain metastases (WHOBI-STER): A prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities and quality of life.
Ferini G; Viola A; Valenti V; Tripoli A; Molino L; Marchese VA; Illari SI; Rita Borzì G; Prestifilippo A; Umana GE; Martorana E; Mortellaro G; Ferrera G; Cacciola A; Lillo S; Pontoriero A; Pergolizzi S; Parisi S
Clin Transl Radiat Oncol; 2022 Jan; 32():52-58. PubMed ID: 34926839
[TBL] [Abstract][Full Text] [Related]
14. Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center.
Adegboyega B; Joseph A; Alabi A; Omomila J; Ngema LM; Ainsworth V; Chin J; Evbuomwan MO; Ngwa W
BMC Cancer; 2023 Dec; 23(1):1233. PubMed ID: 38098061
[TBL] [Abstract][Full Text] [Related]
15. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis.
Khan M; Lin J; Liao G; Li R; Wang B; Xie G; Zheng J; Yuan Y
Tumour Biol; 2017 Jul; 39(7):1010428317702903. PubMed ID: 28675121
[TBL] [Abstract][Full Text] [Related]
16. Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial.
De Puysseleyr A; Van De Velde J; Speleers B; Vercauteren T; Goedgebeur A; Van Hoof T; Boterberg T; De Neve W; De Wagter C; Ost P
Radiat Oncol; 2014 Jul; 9():170. PubMed ID: 25074394
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.
Rahimy E; Dudley SA; von Eyben R; Pollom EL; Seiger K; Modlin L; Wynne J; Fujimoto D; Jacobs LR; Chang SD; Gibbs IC; Hancock SL; Adler JR; Li G; Choi CYH; Soltys SG
Am J Clin Oncol; 2021 Nov; 44(11):588-595. PubMed ID: 34670228
[TBL] [Abstract][Full Text] [Related]
18. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Soffietti R; Kocher M; Abacioglu UM; Villa S; Fauchon F; Baumert BG; Fariselli L; Tzuk-Shina T; Kortmann RD; Carrie C; Ben Hassel M; Kouri M; Valeinis E; van den Berge D; Mueller RP; Tridello G; Collette L; Bottomley A
J Clin Oncol; 2013 Jan; 31(1):65-72. PubMed ID: 23213105
[TBL] [Abstract][Full Text] [Related]
19. Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial.
Herrlinger U; Schäfer N; Fimmers R; Griesinger F; Rauch M; Kirchen H; Roth P; Glas M; Bamberg M; Martus P; Thiel E; Korfel A; Weller M
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1815-1821. PubMed ID: 28434043
[TBL] [Abstract][Full Text] [Related]
20. Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trial.
Hartgerink D; Bruynzeel A; Eekers D; Swinnen A; Hurkmans C; Wiggenraad R; Swaak-Kragten A; Dieleman E; van der Toorn PP; van Veelen L; Verhoeff JJC; Lagerwaard F; de Ruysscher D; Lambin P; Zindler J
Ann Palliat Med; 2022 Apr; 11(4):1197-1209. PubMed ID: 34806396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
